DavidTRubinMD

PubMed

• 710 citations
  A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3.
  Michael H. Glickman, David T. Rubin, Olivier Coux, Inge Wefes, Günter Pfeifer
  Cell. 1998-09-04
• 93 citations
  Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
  William J Sandborn, Geert R D'Haens, Walter Reinisch, Julián Panés, Daphne Chan
  Gastroenterology. 2022-05-01
• 53 citations
  Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, ran...
  Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, Millie D. Long, Matthieu Allez
  The Lancet. Gastroenterology & Hepatology. 2021-11-17

Journal Articles

• Discussion of Code Status in the Peri-Endoscopic Period  
  Vijaya L Rao, David T Rubin, Lauren D Feld, Nature
• Correction to: Risk Factors for Clostridium Difficile Isolation in Inflammatory Bowel Disease: A Prospective Study  
  Sushila Dalal, Vijaya L Rao, Laura R Glick, Russell Cohen, Ayal Hirsch, Dejan Micic, Joel Pekow, Atsushi Sakuraba, David T Rubin, Digestive Diseases and Sciences
• Utility of Video Capsule Endoscopy for Longitudinal Monitoring of Crohn’s Disease Activity in the Small Bowel: A Prospective Study  
  Gil Y Melmed, Marla C Dubinsky, David T Rubin, Shabana F Pasha, Atsushi Sakuraba, Felix Tiongco, Ira Shafran, Jonathan A Leighton, Gastrointestinal Endoscopy
• Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer  
  Andrew D Feld, Lauren D Feld, David T Rubin, Nature
• Chromoendoscopy for Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Disease  
  Shah SA, Rubin DT, Farraye FA, Curr Gastroenterol Rep, 9/1/2014
• Real-world assessment of therapy changes, suboptimal treatment, and associated costs in patients with ulcerative colitis or Crohn's Disease  
  Rubin DT, Mody R , Davis KL , Wang CC, Aliment Pharmacol Ther, 5/1/2014
• Use of serum infliximab level prior to cyclosporine salvage therapy in severe ulcerative colitis  
  Chapman C, Stein A, Rubin DT, American College of Gastroenterology Case Rep J, 4/1/2014
• 50 Gastrointestinal Cases and Associated Imaging  
  Stein AC, Rubin DT, Gastroenterol, 12/1/2013
• Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case-Control Study  
  Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR, Clin Gastroenterol Hepatol, 12/1/2013
• Editorial: Curbing our Enthusiasm for Fecal Transplantation in Ulcerative Colitis  
  Rubin DT, Am J Gastroenterol, 10/1/2013
• Chronic pouchitis versus recurrent Crohn's disease: A diagnostic challenge  
  Weber CR, Rubin DT, Dig Dis Sci, 10/1/2013
• Initial experience of a through-the-scope balloon device for ileal intubation in Crohn's disease  
  Rubin DT and Goeppenger SR, Gastrointest Endosc, 10/1/2013
• Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients  
  Ali T, Madhoun MF, Orr WC, Rubin DT, Inflamm Bowel Dis, 10/1/2013
• Patient perceptions of fecal microbiota transplantation for ulcerative colitis  
  Kahn SA, Vachon A, Rodriquez D, Goeppinger SR, Surma B, Marks J, Rubin DT, Inflamm Bowel Dis, 6/1/2013
• What you see is not always what you get: raising the bar on clinical trial methodology in ulcerative colitis  
  Rubin DT, Gastroenterol, 6/1/2013
• Serum adalimumab concentration and clinical remission in patients with Crohn's disease  
  Chiu YL, Li JL, Rubin DT, Vermeire S, Louis E, Robinson AM, Lomax KG, Pollack PF, Paulson SK, Inflamm Bowel Dis, 5/1/2013
• Fecal microbiota transplantation: A new therapy for IBD? Proceeding with caution  
  Kahn SA, Goeppinger SR, Rubin DT, Inflamm Bowel Dis Monit, 1/1/2013
• Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis  
  Calabrese E, Yanai H, Shuster D, Rubin DT, Hanauer SB, J Crohns Colitis, 8/1/2012
• Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy  
  Hoentjen F, Hanauer SB, Hart J, Rubin DT, J. Clin Gastroenterol, 7/31/2012
• Secondary gastrointestinal cancer in childhood cancer survivors: a childhood cancer survivor study  
  Henderson TO, Oeffinger KC, Whitton J, Leisenring W, Neglia J, Meadows A, Crotty C, Rubin DT, Diller L, Inskip P, Smith SA, Stovall M, Constine LS, Hammond S, Armstron..., Ann of Intern Med, 6/5/2012
• Assessment of variables associated with smoking cessation in Crohn's disease  
  Leung Y, Kaplan GG, Rioux KP, Hubbard J, Kamhawi S, Stasiak L, Cohen RD, Devlin SM, Panaccione R, Hanauer SB, Rubin DT, Dig Dis Sci, 4/1/2012
• Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease  
  Ali T, Yun L, Rubin DT, World J Gastroenterol, 1/21/2012
• Total abdominal colectomy for refractory ulcerative colitis: surgical treatment in evolution  
  Fichera A, Zoccali M, Felice C, Rubin DT, J Gastrointest Surg, 11/1/2011
• A practical, evidence-based guide to the use of adalimumab in Crohn's disease  
  Rubin DT, Panaccione R, Chao J, Robinson AM, Curr Med Res Opin, 9/1/2011
• Rifaximin Is effective for the treatment of Clostridium difficile-associated diarrhea: Results of an open-label pilot study  
  Rubin DT, Sohi S, Glathar M, Thomas T, Yadron N, Surma BL, Gastroenterol Res Pract, 9/1/2011
• Join now to see all

Books/Book Chapters

• Clinical Dilemmas in Inflammatory Bowel Disease 
  Chapter: What can we do with Crohn's patients refractory to anti-TNF therapy? 
  Rubin DTEditors: Irving P, Siegel CA, Rampton DS, Shanahan F.Wiley Blackwell2011
• Pocket Guide to IBD 
  Chapter: Colorectal Cancer in Inflammatory Bowel Disease. 
  Rubin DTEditors: Dubinsky MC, Friedman S.Slack Inc.Edition 2nd,2011
• Atlas of CT Colonoscopy 
  Chapter: Epidemiology and Screening of Colon Cancer. 
  Hassan C, Lang GD, Rubin DTEditors: Dachman AH, Laghi A.SpringerEdition 2nd,2010
• IBD Yearbook 
  Chapter: Genetic Testing for Inflammatory Bowel Disease: Current Knowledge and Implications for the Future. 
  Lewis JR, Rubin DTEditors: Bernstein CN.2010
• The Changing World of Inflammatory Bowel Disease: Impact of Generation, Gender, and Global Trends 
  Chapter: Chronic Care of Inflammatory Bowel Disease. 
  Page 205 - 213Rubin DTEditors: Dubinsky MC, Scherl EJ.Slack Inc.2009
• Chronic Inflammation of Liver and Gut (Falk Symposium 163) 
  Chapter: Prevention of cancer in inflammatory bowel disease and the potential chemopreventive effect of aminosalicyclates. 
  Page 55 - 66Rubin DTSpringer and Falk Foundation2009
• Early Detection and Prevention in Colorectal Cancer 
  Chapter: Novel Tests for Colorectal Cancer Screening: CT Colonography and Beyond. 
  Rubin DT, Kavitt REditors: Kim K.Slack Inc.2009
• Clinician 
  Chapter: The IBD Challenge. 
  Hanauer SB, Present DH, Rubin DT, Sninsky CA2007
• Intestinal Inflammation and Colorectal Cancer 
  Chapter: Endoscopic guidelines for Hereditary Non-polyposis Colorectal Cancer, Familial Adenomatous Polyposis, Inflammatory Bowel Disease and Sporadic Colorectal Cancer. 
  Page 131 - 151Rubin DT, Hetzel JTEditors: Gasche C, Gassull M, Herrerías Gutiérrez J.M, Monteiro E.Springer, Dordrecht, The Netherlands2007
• Advances in Digestive Disease 
  Chapter: The Promise of Chemoprevention of Colorectal Cancer in Inflammatory Bowel Disease. 
  Rubin DTEditors: Colin W. Howden.American Gastroenterological Association Institute Press, Bethesda, M2007
• Crohn's Disease 
  Chapter: Crohn's Disease Patient at High Risk for Colorectal Cancer. 
  Kozuch PL, Rubin DTEditors: Gary Lichtenstein.2005
• Straight Talk About Hospitalization: A Guide for IBD Patients. (Handbook) 
  Reiss M, Dubinsky MC, Rubin DT2005
• Pocket Guide to Inflammatory Bowel Disease 
  Chapter: Cancer and IBD. 
  Rubin DTEditors: Sunanda V. Kane and Marla C. Dubinsky.Cambridge University Press2005
• Principles of Critical Care 
  Chapter: Cirrhosis in critical care. 
  Satoskar R, Rubin DTEditors: Schmidt, Hall, Wood.Edition 3rd,2005
• Rev Gastroenterol Disord 
  Chapter: Role of antibiotics in the management of inflammatory bowel disease: A review. 
  Rubin DT, Kornbluth A2005
• We Care Handbook 
  Chapter: "Colorectal Cancer in Inflammatory Bowel Disease." 
  Rubin DT2005
• Digestive Diseases Supplementary Educational Program IV for the AGA 
  Chapter: "GI Cancer." 
  Rubin DT2004
• Colorectal Cancer: Multimodality Management 
  Chapter: Virtual colonoscopy for colorectal cancer screening and surveillance. 
  Rubin DT, Dachman AHEditors: Leonard Saltz.Humana Press Inc, Totowa NJ2001
• Principles of Critical Care, Companion Handbook 
  Chapter: Gastrointestinal Hemorrhage. 
  Rubin DTEditors: Hall JB, Schmidt GA, Wood LDH.New YorkEdition 2nd,1999
• Principles of Critical Care, Companion Handbook 
  Chapter: Acute and Chronic Hepatic Disease. 
  Rubin DTEditors: Hall JB, Schmidt GA, Wood LDH.New YorkEdition 2nd,1999
• Principles of Critical Care, Companion Handbook 
  Chapter: Acute Pancreatitis. 
  Rubin DTEditors: Hall JB, Schmidt GA, Wood LDH.New YorkEdition 2nd,1999
• Contribution to the Geriatrics Syllabus for the Hartford Geriatrics Initiative at the University of Chicago Department of Medicine 
  Chapter: A review of erectile dysfunction. 
  Rubin DT1997
• Progress in Thyroid Research 
  Page 155 - 158Magner J, Klibanski A, Fein H, Smallridge R, Blackard W, Young W Jr, Ferriss JB, Murphy D, Kane J, Rubin DTEditors: Gordon, Gross, and Hennemann.1991
• Join now to see all

Abstracts/Posters

• Remission status after maintenance treatment with MMX Mesalamine in mile-to-moderate ulcerative colitis (UC): comparison of patients (PTS) in complete remission (CR) v...
  Rubin DT, Inglis S, Magee E, Streck P, Solomon D, D'Haens G, Canadian Digestive Diseases Week, Toronto, Ontario, Canada, 1/1/2014
• Improvements in health-related quality of life in patients with Ulcerative Colitis treated with vedolizumab.
  Feagan B, Colombel JF, Rubin DT, Mody R, Sankoh S, Lasch K, Congress of ECCO, Copenhagen, Denmark, 1/1/2014
• Recommendations for creating a high quality endoscopy report for Inflammatory Bowel Disease patients: Results from a RAND-appropriateness panel.
  Delvin SM, Melmed GY, Irving PM, Rubin DT, Kornbluth A, Kozuch PL, Raffals LE, Velayos FS, Sparrow MP, Baidoo L, Bressler B, Chiefetz AS, Jones J, Kaplan GG, Greene J,..., Congress of ECCO, Copenhagen, Denmark, 1/1/2014
• Remission status and maintenance therapy outcomes in patients with mild-to-moderate Ulcerative Colitis (UC): Results from the MOMENTUM study.
  D'haens G, Inglis S, Magee E, Streck P, Solomon D, Rubin DT, Congress of ECCO, Copenhagen, Denmark, 1/1/2014
• Long-Term Efficacy of Vedolizumab Therapy for Crohn's Disease.
  Hanauer SB, Rutgeerts P, Xu J, Rubin DT, Smyth M, Abhyankar B, United European Gastroenterology Week, Austria, Vienna, 1/1/2014
• Budesonide foam for ulcerative proctitis (UP) and Ulcerative proctosigmoiditis (UPS): Subgroup analyses of 2 randomized, placebo controlled, phase 3 studies.
  Bosworth B, Sandborn W, Rubin DT, Yu J, Barrett A, Bortey E, Forbes W, American College of Gastroenterology, Philadelphia, PA, 1/1/2014
• Efficacy and tolerability of budesonide foam with or without baseline 5-aminosalicylic acid use in patients with ulcerative proctitis (UP) or ulcerative proctosigmoidi...
  Sandborn W, Bosworth B, Rubin DT, Yu J, Barnett A, Paterson C, Forbes W, American College of Gastroenterology, Philadelphia, PA, 1/1/2014
• Efficacy of high-dose versus low-dose methotrexate in combination therapy for inflammatory bowel disease.
  Colman R, Rubin DT, American College of Gastroenterology, Philadelphia, PA, 1/1/2014
• Long-term efficacy of vedolizumab therapy for Crohn's disease.
  Hanauer Stephen, Rutgeerts, Xu J, Rubin DT, Smyth M, Abhyankar B, American College of Gastroenterology, Philadelphia, PA, 1/1/2014
• Fecal Apha 1-antitrypsin as a biomarker for disease activity in ulcerative colitis.
  Colman R, Rubin DT, American College of Gastroenterology, Philadelphia, PA, 1/1/2014
• Objective sleep quality assessment using wrist actigraphy in patients with ulcerative colitis.
  Kinnucan J, Goeppinger SR, Tomal J, Ackerman A, Arora V, Ali T, Rubin DT, American College of Gastroenterology, Philadelphia, PA, 1/1/2014
• Assessment of clinicians' knowledge and attitudes regarding sleep quality of their gastrointestinal patients.
  Kinucan J, Kassim O, Rubin DT, American College of Gastroenterology, Philadelphia, PA, 1/1/2014
• Sleep quality and quality of life improve over time in patients with inflammatory bowel disease.
  Kinnucan J, Goeppinger SR, Rubin DT, American College of Gastroenterology, Philadelphia, PA, 1/1/2014
• Crohn's disease behavior as a risk factor for loss of maintenance of remission in patients treated with certolizumab pegol: Results from the PRECiSE 3 study.
  Rubin DT, Randall C, Coarse J, Kosutic G, Spearman M, Ambarkhane S, Jojic N, American College of Gastroenterology, Philadelphia, PA, 1/1/2014
• Addressing sexual function in patients with IBD: Results of a national survey of U.S. GI physicians.
  Christensen B, Goeppinger SR, Rubin DT, American College of Gastroenterology, Philadelphia, PA, 1/1/2014
• Is asacol use associated with congenital anomalies> Results from a nationwide prospective pregnancy registry.
  Singh A, Martin CF, Kane SF, Dubinsky M, Nguyen DD, McCabe RP, Rubin DT, Scherl EJ, Mahadevan U, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.
  Sakuraba A, Annunziata ML, Cohen RD, Hanauer SB, Rubin DT, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Phase 2b randomized placebo-controlled spectral markers as biomarkers for colonic chemoprevention with aspirin: Correlation with rectal apoptosis but not proliferation.
  Roy HK, Radosevich A, Wali RK, Umar A, Della'Zanna G, Janovic B, Goldberg MJ, Bianchi LK, Rubin DT, Rodriguez LM, Tsang TK, Turzhitsky B, Shklovskaya J, Skripkauskas S..., Digestive Diseases Week, Orlando, FL, 1/1/2013
• Health plan paid costs and drivers of health care costs for patients with Crohn's disease insured at six different commercial health plans in the United States.
  Rubin DT, Colletti RB, Sharma BK, Thompson A, Krueger A, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Association between suboptimal therapy and health care costs in inflammatory bowel disease.
  Davis KL, Mody R, Rubin DT, Wang CC, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Inflammatory bowels disease my not be a risk factor for colorectal cancer in elderly Americans: Results from the SEER-Medicare database.
  Kolodziej L, Bellaguarda E, Chuanhong L, Rubin DT, Kupfer S, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Colletti RB, Rubin DT, Sharma BK, Thompson A, Krueger A, Digestive Diseases Week, Orlando, FL, 1/1/2013
• The effect of ulcerative colitis remission status on the ability to maintain or achieve clinical and endoscopic remission after 12-month maintenance treatment with MMx...
  Rubin DT, Inglis S, Magoo E, Streck P, Solomon DM, D'Haens GR, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Development of IBD patient-driven health maintenance checklist.
  Goeppinger SR, Cohn A, Rubin DT, Digestive Diseases Week, Orlando, FL, 1/1/2013
• The CCFA national survey of healthcare access in inflammatory bowel disease (IBD).
  Rubin DT, Goeppinger SR, Kim S, Margolese J, Rodriquez D, Rosh J, Rubin M, Kornbluth A, American College of Gastroenterology, San Diego, CA, 1/1/2013
• Join now to see all

Lectures

• Ulcerative Colitis Medical Management 
  AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/10/2018
• ACG Annual Debrief: IBD Highlights at This Year’s Annual Meeting 
  AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/10/2018
• Challenging IBD Situations 
  AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/7/2018
• Personalized IBD Management: Best Practices for Therapeutic Drug Monitoring and for Managing Treatment Failures 
  AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/5/2018
• "Mucosal Healing in IBD-Research or Clinical Endpoint?" 
  Miami, FL - 1/1/2014
• "Biologic Therapy in Crohn's Disease: When and How? Refractory Crohn's Disease" 
  Las Vegas, NV - 1/1/2014
• "Current Role of Biologics in IBD" 
  Kansas City, MO - 1/1/2014
• "IBD in Special Situations (pregnancy, immunocompromised host, etc.)" 
  Kansas City, MO - 1/1/2014
• "Crohn's Disease" 
  Orlando, FL - 1/1/2014
• "Out of the Box therapies for IBD" 
  San Francisco, CA - 1/1/2014
• "Diagnosis of IBD" 
  Chicago, IL - 1/1/2014
• "Up-to-date UC therapy in US" 
  Chicago, IL - 1/1/2014
• "Evolving Approaches to Current Clinical Challenges" 
  Chicago, IL - 1/1/2014
• "Optimization of therapies for IBD: How to fine tune management." 
  Chicago, IL - 1/1/2014
• "Anti-integrin Therapy in IBD: When to use, how to choose." 
  Chicago, IL - 1/1/2014
• "Mastering Clinical Challenges and Emerging Therapies in IBD: Individualizing our Approach to IBD" 
  Chicago, IL - 1/1/2014
• "How Good are Biologics?" 
  Boston, MA - 1/1/2014
• "How and When to Screen for Cancer in IBD" 
  Philadelphia, PA - 1/1/2014
• "Case Studies in Social Media: Dos and Don'ts" 
  Philadelphia, PA - 1/1/2014
• "Choosing and Monitoring Biologic Therapy for IBD." 
  Philadelphia, PA - 1/1/2014
• "Ulcerative Colitis: Do we still need surveillance?" 
  Toronto, Ontario, Canada - 1/1/2014
• "Can I Predict the Clinical Outcome of My IBD?" 
  Toronto, Ontario, Canada - 1/1/2014
• "Practical Management of Pouchitis" 
  Toronto, Ontario, Canada - 1/1/2014
• "Individualized Care in IBD Management" 
  Copenhagen, Denmark - 1/1/2014
• "Keynote Lecture High quality IBD Centres: how to build and how to monitor?" 
  Amsterdam - 1/1/2014
• Join now to see all

Other

• A suggested approach to incidental illeitis. 
  Rubin DT
  http://www.thecdwg.org
• "Sure It's Just Gas? 5 Surprising Culprits Of Sharp Stomach Pain" 
  David T. Rubin, MD, Prevention
  http://www.prevention.com/health/health-concerns/constipation-gas-and-other-causes-stomach-pain
  9/25/2014
• "Disease that caused Rick Davis death rarely fatal." 
  David T. Rubin, MD, Courier & Press
  http://www.courierpress.com/news/local-news/disease-that-caused-rick-davis-death-rarely-fatal_62503951
  7/9/2014
• "This Is Only A (Medical) Test." 
  David T. Rubin, MD, Real Simple Magazine, July Issue
  7/1/2014
• "6 DIY Medical Treatments You Shouldn't Try at Home." (Yahoo shine editorial addressing trends in self administration of medical treatments.) 
  David T. Rubin, MD, Yahoo Shine, Section 1: Fecal Transplants
  https://shine.yahoo.com/healthy-living/6-diy-medical-treatments-shouldn-t-try-home-154200290.html
  5/5/2014
• "Debate: Mucosal healing should be the endpoint of therapy in UC" 
  David T. Rubin, MD, Great Debates and Updates in IBD
  San Francisco, CA - 1/1/2014
• "Debate: Is There Still a Role for Maintenance Therapy with 6MP or Methotrexate? Con" 
  David T. Rubin, MD, 8th Annual CME course entitled Inflammatory Bowel Disease: The Art and Science in the Diagnosis and
  Boston, MA - 1/1/2014
• "Social Media Twitter Feed" 
  David T. Rubin, MD
  http://www.twitter.com/IBDMD
  1/1/2014
• "Considerations for the Use of Biologics in Moderate to Severe Crohn's Disease: A Case-Based Approach." 
  Rubin DT, Penn State/ PVI Online CME Program
  http://www.peerviewpress.com/r303
  10/31/2013
• "New, Experimental Drug for IBD: Q&A With Digestive Expert David T. Rubin, MD" 
  David T. Rubin, MD
  http://www.everydayhealth.com/digestive-health/a-wonder-drug-for-ibd-qa-with-digestive-expert-david-rubin-md-6201.aspx
  8/22/2013
• "Optimizing Treatment of Mild to Moderate Ulcerative Colitis: A Case-Based Perspective (online CME program)" 
  Rubin DT, Dubinsky MC
  http://www.medscape.org/viewarticle/808206
  7/29/2013
• "Expert Insights: Modern Management of Mild-Moderate Ulcerative Colitis (Online CME program)" 
  Rubin DT, Hanauer SB, Sandborn WJ
  http://www.medscape.org/viewarticle/778714
  2/26/2013
• Videos: "Update on dysplasia detection: Should you use chromoendoscopy?" 
  David T. Rubin, MD, Mastering Clinical Challeges and Emerging Therapies in IBD: Individualizing our Approach to IBD
  Chicago, IL - 1/1/2013
• "Pro: In patients with both CMV and steroid refractory ulcerative colitis, you must treat the ulcerative colitis with biologics, but you do not need to also treat the ... 
  David T. Rubin, MD
  Hollywood, FL - 1/1/2013
• Emmi interactive patient information for IBD. 
  Siegel C, Rubin DT, Sands B, CCFA and Emmi
  1/1/2013
• "Best of American College of Gastroenterology in IBD." 
  Rubin DT, Gastroenterology & Endoscopy News
  1/1/2013
• "IBD Blogger Summit" 
  Rubin DT, Cooney Waters
  11/26/2012
• Co-Chair, CCFA Optimizing IBD Patient Care: "Advances in IBD" Conference Highlights, CME program, (on line CME program) 
  David T. Rubin, MD
  http://www.mycme.com/optimizing-ibd-patient-care-advances-in-ibd-conference-highlights/activity/1180/
  11/7/2012
• Management of acute severe ulcerative colitis. 
  Rubin DT, Audio-Digest Gastroenterology
  8/21/2012
• "Optimizing Use of Biologics in Moderate to Severe Crohn Disease: A Practical Approach." 
  Rubin DT, Corey SA, Medscape Education Gastroenterology
  http://www.medscape.org/viewarticle/767665
  7/27/2012
• "Healthbeat Report: Ulcerative Colitis" 
  David T. Rubin, MD, ABC News Chicago
  http://abclocal.go.com/wls/story?section=news/health&id=8601197
  3/29/2012
• "Convincing new evidence about benefits of colonoscopy." 
  David T. Rubin, MD, ABC News Chicago
  http://abclocal.go.com/wls/story?section=news/health&id=8593344
  3/23/2012
• Approaches the Polyps and Raised Lesions in IBD. 
  Rubin DT, Audio-Digest Gastroenterology
  3/7/2012
• Debate: What Should Be the End Point of Therapy? 
  Rubin DT, Dubinsky M, Audio-Digest Gastroenterology
  2/21/2012
• "Ally's Law" Inflammatory Bowel Disease." 
  Ally Bain; Dr. David T. Rubin, About.com
  http://ibdcrohns.about.com/b/2012/02/03/ally-bain-and-dr-david-t-rubin-discuss-allys-law.htm
  2/3/2012
• Join now to see all